Christopher Su
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Renal cell carcinoma treatment 2
- Oncology 9
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Brie Williams (2 shared papers)Rebecca L. Sudore (2 shared papers)Ajjai Alva (7 shared papers)Rashmi Sharma (2 shared papers)Ryan D. McMahan (2 shared papers)Haiying Cheng (7 shared papers)Nityam Rathi (2 shared papers)Xīn Gào (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)JAMA Oncology (2 papers)Clinical Lung Cancer (2 papers)Cancers (2 papers)Transplantation and Cellular Therapy (2 papers)
- Partner nations
- United StatesItalySouth Africa
In The Last Decade
Christopher Su
26 papers receiving 304 citations
Peers
Comparison fields: 5 of 55
- Oncology 109
- Pulmonary and Respiratory Medicine 87
- Applied Microbiology and Biotechnology 4
- Hematology 17
- Cancer Research 18
Countries citing papers authored by Christopher Su
This map shows the geographic impact of Christopher Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Su more than expected).
Fields of papers citing papers by Christopher Su
This network shows the impact of papers produced by Christopher Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Su. The network helps show where Christopher Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 95 | |
| 2 | 2014 | 33 | |
| 3 | 2021 | 23 | |
| 4 | 2024 | 18 | |
| 5 | 2019 | 18 | |
| 6 | 2021 | 17 | |
| 7 | 2023 | 12 | |
| 8 | 2018 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2019 | 10 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 7 | |
| 13 | 2024 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2021 | 4 | |
| 18 | 2017 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2020 | 2 |
About Christopher Su
Christopher Su is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Economics and Econometrics, Surgery and Public Health, Environmental and Occupational Health, having authored 30 papers that have together received 308 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Multiple Myeloma Research and Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Oncology (109 citations), Pulmonary and Respiratory Medicine (87 citations), Applied Microbiology and Biotechnology (4 citations), Hematology (17 citations) and Cancer Research (18 citations). Christopher Su has collaborated with scholars based in United States, Italy and South Africa. Frequent co-authors include Brie Williams, Rebecca L. Sudore, Ajjai Alva, Rashmi Sharma, Ryan D. McMahan, Haiying Cheng, Nityam Rathi, Xīn Gào, Praful Ravi and David F. McDermott. Their work appears in journals such as Journal of Clinical Oncology, JAMA Oncology, Clinical Lung Cancer, Cancers and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.